Showing 2,321 - 2,340 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant co) OR (significant factor)) decrease ))', query time: 0.58s Refine Results
  1. 2321

    Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
  2. 2322

    NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  3. 2323

    Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  4. 2324

    Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  5. 2325
  6. 2326
  7. 2327
  8. 2328
  9. 2329
  10. 2330
  11. 2331
  12. 2332

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
  13. 2333
  14. 2334
  15. 2335
  16. 2336
  17. 2337
  18. 2338
  19. 2339

    Flow chart. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
  20. 2340